Phio Pharmaceuticals Corp. Made Big Gain
Wed, Apr 09, 2025 at 07:56 PM
Phio Pharmaceuticals Corp. (PHIO:NASDAQ) rocketted at $1.54, representing a gain of 52.5%. On Wed, Apr 09, 2025, PHIO:NASDAQ touched a New 2-Week High of $1.54. The stock got featured on our News Catalysts scanner on Wed, Apr 09, 2025 at 10:51 AM in the 'BIOTECH' category. From Wed, Mar 26, 2025, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Wed, Apr 09, 2025 at $2.73 with a volume of 150M+.
About Phio Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Top 10 Gainers:
- Venus Concept Inc. (VERO:NASDAQ), 210.07%
- BeLive Holdings (BLIV:NASDAQ), 105.13%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 104.13%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Direxion Daily Semiconductor Bull 3X Shares (SOXL:NYSE), 54.79%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 52.48%
- Direxion Daily AMD Bull 2X Shares (AMUU:NASDAQ), 48.2%
- Signing Day Sports Inc. (SGN:NYSEMKT), 47.63%
- Direxion Daily TSLA Bull 2X Shares (TSLL:NASDAQ), 45.21%
- Color Star Technology Co. Ltd. (ADD:NASDAQ), 44.22%